DELAMANID, 25mg, disp. tab., blister
STD
DORADELA2TD1
Valid Article
HS Code:
300490
Last Updated on:
22/10/2024, 13:22:16
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AK06
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
DELAMANID
- In the WHO list of Essential Medicines 2023 (Complementary List)
Therapeutic Action
Nitroimidazole antibactericidal
Indications
Drug-Resistant Tuberculosis (DR-TB), in combination with other TB medicines
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
The 25 mg dispersible tablet is intended for paediatric use, to be dispersed in water or fruit juice.
Tablets should be swallowed whole if possible.
To be taken with food.
Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.
The quantity to be ordered is calculated per tablet, not per blister.
Precautions for Use
May cause QT prolongation.
Storage
Below 25ºC - Protect from humidity